TY - JOUR
T1 - Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding
AU - Isokuortti, Harri
AU - Iverson, Grant L.
AU - Posti, Jussi P.
AU - Ruuskanen, Jori O.
AU - Brander, Antti
AU - Kataja, Anneli
AU - Nikula, Milaja
AU - Öhman, Juha
AU - Luoto, Teemu M.
N1 - Funding Information:
TL and JP have received funding from Government’s Special Financial Transfer tied to academic research in Health Sciences (Finland). JP was funded by the Academy of Finland (Grant #17379) and Maire Taponen Foundation. TL has received research grants from the Finnish Brain Foundation sr, the Emil Aaltonen Foundation sr, the Maire Taponen Foundation, the Science Fund of the City of Tampere, and the Finnish Medical Society Duodecim.
Funding Information:
Conflict of Interest: GI acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, ImPACT Applications, Inc., and the Spaulding Research Institute. He serves as a strategic scientific advisor for NanoDX (formerly BioDirection, Inc.). JP has received speaker’s fees from Orion corporation and Finnish Medical Association, and a travel grant from Stryker Corporation. JR has received speaker’s fees from Orion Corporation, Bayer and Merck, and a travel grant from Boehringer Ingelheim. TL has received speaker’s fees from Orion Corporation, Novartis Finland, and the Finnish Medical Society Duodecim. JR was employed by company Medbase Ltd.
Publisher Copyright:
© Copyright © 2021 Isokuortti, Iverson, Posti, Ruuskanen, Brander, Kataja, Nikula, Öhman and Luoto.
PY - 2021
Y1 - 2021
N2 - Background: Serotonergic antidepressants may predispose to bleeding but the effect on traumatic intracranial bleeding is unknown. Methods: The rate of intracranial bleeding in patients with antidepressant medication was compared to patients not antidepressants in a cohort of patients with acute head injury. This association was examined by using a consecutive cohort of head trauma patients from a Finnish tertiary center emergency department (Tampere University Hospital, Tampere, Finland). All consecutive (2010–2012) adult patients (n = 2,890; median age = 58; male = 56%, CT-positive = 22%, antithrombotic medication users = 25%, antidepressant users = 10%) who underwent head CT due to head trauma in the emergency department were included. Results: Male gender, GCS <15, older age, and anticoagulation were associated with an increased risk for traumatic intracranial bleeding. There were 17.8% of patients not taking antidepressants and 18.3% of patients on an antidepressant who had traumatic intracranial bleeding (p = 0.830). Among patients who were taking antithrombotic medication, 16.6% of the patients not taking antidepressant medication, and 22.5% of the patients taking antidepressant medication, had bleeding (p = 0.239). In a regression analysis, traumatic intracranial hemorrhage was not associated with antidepressant use. Conclusions: Serotonergic antidepressant use was not associated with an increased risk of traumatic intracranial hemorrhage.
AB - Background: Serotonergic antidepressants may predispose to bleeding but the effect on traumatic intracranial bleeding is unknown. Methods: The rate of intracranial bleeding in patients with antidepressant medication was compared to patients not antidepressants in a cohort of patients with acute head injury. This association was examined by using a consecutive cohort of head trauma patients from a Finnish tertiary center emergency department (Tampere University Hospital, Tampere, Finland). All consecutive (2010–2012) adult patients (n = 2,890; median age = 58; male = 56%, CT-positive = 22%, antithrombotic medication users = 25%, antidepressant users = 10%) who underwent head CT due to head trauma in the emergency department were included. Results: Male gender, GCS <15, older age, and anticoagulation were associated with an increased risk for traumatic intracranial bleeding. There were 17.8% of patients not taking antidepressants and 18.3% of patients on an antidepressant who had traumatic intracranial bleeding (p = 0.830). Among patients who were taking antithrombotic medication, 16.6% of the patients not taking antidepressant medication, and 22.5% of the patients taking antidepressant medication, had bleeding (p = 0.239). In a regression analysis, traumatic intracranial hemorrhage was not associated with antidepressant use. Conclusions: Serotonergic antidepressant use was not associated with an increased risk of traumatic intracranial hemorrhage.
KW - anticoagulation
KW - antidepressant agents
KW - antithrombotic agents (MeSH)
KW - brain injuries
KW - intracranial hemorrhages
KW - traumatic
U2 - 10.3389/fneur.2021.758707
DO - 10.3389/fneur.2021.758707
M3 - Article
AN - SCOPUS:85118999585
SN - 1664-2295
VL - 12
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 758707
ER -